HAMILTON, Bermuda, May 05, 2022 (GLOBE NEWSWIRE) -- Enstar Group Limited (Nasdaq: ESGR) filed its quarterly report on Form 10-Q with the SEC earlier today, reporting a net loss of $282 million and return on equity of (5.0)% for the three months ended March 31, 2022.
Commenting on the Company’s results, Enstar CEO Dominic Silvester said:
"We started the year by signing one of our largest ever loss portfolio transactions and completing another successful debt raise at competitive rates, while our financial results in the first quarter reflect rising interest rates and economic uncertainty.
We remain focused on delivering long-term value and are well positioned to maintain our momentum during these volatile times."
First quarter results included:
*Non-GAAP measure; refer to "Non-GAAP Financial Measures" further below for explanatory notes and a reconciliation to the most directly comparable GAAP measure.
Operational Highlights
_______________1 The amount of net loss reserves assumed, as well as the premium and limit amounts provided in the LPT agreement, will be adjusted for claims paid between October 1, 2021 and the closing date of the transaction pursuant to terms of the contract.
Key Financial and Operating Metrics
We use the following GAAP and Non-GAAP measures to monitor the performance of and manage the company:
Three Months Ended | ||||||||||||||
March 31, 2022 | March 31, 2021 | $ Change | % / pp / bp Change | |||||||||||
(in millions of U.S. dollars, except per share data) | ||||||||||||||
Key Earnings Metrics | ||||||||||||||
Net (loss) earnings attributable to Enstar ordinary shareholders | $ | (282 | ) | $ | 183 | $ | (465 | ) | (254 | ) % | ||||
Adjusted operating (loss) income attributable to Enstar ordinary shareholders* | $ | (75 | ) | $ | 295 | (370 | ) | (125 | ) % | |||||
ROE | (5.0 | )% | 3.0 | % | (8.0 | ) pp | ||||||||
Annualized ROE | (20.2 | )% | 11.9 | % | (32.1 | ) pp | ||||||||
Adjusted ROE* | (1.4 | )% | 5.4 | % | (6.8 | ) pp | ||||||||
Annualized Adjusted ROE* | (5.7 | )% | 21.7 | % | (27.4 | ) pp | ||||||||
Key Run-off Metrics | ||||||||||||||
Prior period development | $ | 143 | $ | 110 | 33 | 30 | % | |||||||
Adjusted prior period development* | $ | (1 | ) | $ | 26 | (27 | ) | (104 | ) % | |||||
Annualized RLE | 5.1 | % | 5.0 | % | 0.1 | pp | ||||||||
Annualized Adjusted RLE* | 0.0 | % | 1.2 | % | (1.2 | ) pp | ||||||||
Key Investment Return Metrics | ||||||||||||||
TIR | $ | (307 | ) | $ | 159 | (466 | ) | (293 | ) % | |||||
Adjusted TIR* | $ | 27 | $ | 365 | (338 | ) | (93 | ) % | ||||||
Total investable assets | $ | 20,618 | $ | 18,212 | 2,406 | 13 | % | |||||||
Adjusted total investable assets* | $ | 21,139 | $ | 17,983 | 3,156 | 18 | % | |||||||
Annualized investment book yield | 1.91 | % | 1.86 | % | 5 | bp | ||||||||
Annualized TIR | (6.1 | )% | 3.6 | % | (9.7 | ) pp | ||||||||
Annualized Adjusted TIR* | 0.5 | % | 8.4 | % | (7.9 | ) pp | ||||||||
As of | ||||||||||||||
March 31, 2022 | December 31, 2021 | |||||||||||||
Key Shareholder Metrics | ||||||||||||||
Book value per ordinary share | $ | 286.51 | $ | 316.34 | (29.83 | ) | (9.4 | ) % | ||||||
Adjusted book value per ordinary share* | $ | 282.10 | $ | 310.80 | (28.70 | ) | (9.2 | ) % | ||||||
pp - Percentage point(s)bp - Basis point(s)*Non-GAAP measure; refer to "Non-GAAP Financial Measures" further below for reconciliations.
Results of Operations by Segment - For the Three Months Ended March 31, 2022 and 2021
Run-off Segment
The following is a discussion and analysis of the results of operations for our Run-off segment.
Three Months Ended | ||||||||||||||
March 31, 2022 | March 31, 2021 | $ Change | % Change | |||||||||||
(in millions of U.S. dollars) | ||||||||||||||
INCOME | ||||||||||||||
Net premiums earned | $ | 17 | $ | 73 | $ | (56 | ) | (77 | )% | |||||
Other income: | ||||||||||||||
Reduction in estimates of net ultimate defendant A&E liabilities - prior periods | 3 | 9 | (6 | ) | (67 | )% | ||||||||
Reduction in estimated future defendant A&E expenses | — | 3 | (3 | ) | (100 | )% | ||||||||
All other income | 7 | 10 | (3 | ) | (30 | )% | ||||||||
Total other income | 10 | 22 | (12 | ) | (55 | )% | ||||||||
Total income | 27 | 95 | (68 | ) | (72 | )% | ||||||||
EXPENSES | ||||||||||||||
Net incurred losses and LAE: | ||||||||||||||
Current period | 11 | 44 | (33 | ) | (75 | )% | ||||||||
Prior periods: | ||||||||||||||
Reduction in estimates of net ultimate losses | (29 | ) | (25 | ) | (4 | ) | 16 | % | ||||||
Reduction in provisions for ULAE | (21 | ) | (14 | ) | (7 | ) | 50 | % | ||||||
Total prior periods | (50 | ) | (39 | ) | (11 | ) | 28 | % | ||||||
Total net incurred losses and LAE | (39 | ) | 5 | (44 | ) | NM | ||||||||
Acquisition costs | 8 | 29 | (21 | ) | (72 | )% | ||||||||
General and administrative expenses | 39 | 28 | 11 | 39 | % | |||||||||
Total expenses | 8 | 62 | (54 | ) | (87 | )% | ||||||||
SEGMENT NET EARNINGS | $ | 19 | $ | 33 | $ | (14 | ) | (42 | )% | |||||
NM - Not meaningful, we define NM as changes greater than or equal to +/- 300%.
Our Run-off segment net earnings decreased by $14 million, primarily due to:
Investments Segment
The following is a discussion and analysis of the results of operations for our Investments segment.
Three Months Ended | ||||||||||||||
March 31, | ||||||||||||||
2022 | 2021 | $ Change | % Change | |||||||||||
(in millions of U.S. dollars) | ||||||||||||||
INCOME | ||||||||||||||
Net investment income: | ||||||||||||||
Fixed income securities | $ | 68 | $ | 51 | $ | 17 | 33 | % | ||||||
Other investments, including equities | 19 | 14 | 5 | 36 | % | |||||||||
Less: Investment expenses | (11 | ) | (4 | ) | (7 | ) | 175 | % | ||||||
Total net investment income | 76 | 61 | 15 | 25 | % | |||||||||
Net realized losses: | ||||||||||||||
Fixed income securities | (35 | ) | (11 | ) | (24 | ) | 218 | % | ||||||
Other investments, including equities | (2 | ) | 1 | (3 | ) | NM | ||||||||
Net realized losses | (37 | ) | (10 | ) | (27 | ) | 270 | % | ||||||
Net unrealized losses: | ||||||||||||||
Fixed income securities | (293 | ) | (194 | ) | (99 | ) | 51 | % | ||||||
Other investments, including equities | (82 | ) | 184 | (266 | ) | (145 | )% | |||||||
Total net unrealized losses | (375 | ) | (10 | ) | (365 | ) | NM | |||||||
Total income | (336 | ) | 41 | (377 | ) | NM | ||||||||
EXPENSES | ||||||||||||||
General and administrative expenses | 9 | 3 | 6 | 200 | % | |||||||||
Total expenses | 9 | 3 | 6 | 200 | % | |||||||||
Earnings from equity method investments | 31 | 118 | (87 | ) | (74 | )% | ||||||||
SEGMENT NET (LOSS) EARNINGS | $ | (314 | ) | $ | 156 | $ | (470 | ) | NM | |||||
NM - Not meaningful, we define NM as changes greater than or equal to +/- 300%.
Segment net loss from our Investments segment was $314 million for the three months ended March 31, 2022 compared to segment net earnings of $156 million for the same period in 2021, an unfavorable change of $470 million primarily due to:
Income and Earnings by Segment - For the Three Months Ended March 31, 2022, and 2021
Three Months Ended | ||||||||||||||
March 31, 2022 | March 31, 2021 | $ Change | % Change | |||||||||||
(in millions of U.S. dollars) | ||||||||||||||
INCOME | ||||||||||||||
Run-off | $ | 27 | $ | 95 | $ | (68 | ) | (72 | )% | |||||
Enhanzed Re | 14 | — | 14 | NM | ||||||||||
Investments | (336 | ) | 41 | (377 | ) | NM | ||||||||
Legacy Underwriting | 2 | 13 | (11 | ) | (85 | )% | ||||||||
Subtotal | (293 | ) | 149 | (442 | ) | (297 | )% | |||||||
Corporate and other | 3 | 10 | (7 | ) | (70 | )% | ||||||||
Total income | $ | (290 | ) | $ | 159 | $ | (449 | ) | (282 | )% | ||||
SEGMENT NET (LOSS) EARNINGS | ||||||||||||||
Run-off | $ | 19 | $ | 33 | $ | (14 | ) | (42 | )% | |||||
Enhanzed Re | 29 | — | 29 | NM | ||||||||||
Investments | (314 | ) | 156 | (470 | ) | NM | ||||||||
Legacy Underwriting | — | 2 | (2 | ) | (100 | )% | ||||||||
Total segment net (loss) earnings | (266 | ) | 191 | (457 | ) | (239 | )% | |||||||
Corporate and other (1)(2) | (16 | ) | (8 | ) | (8 | ) | 100 | % | ||||||
NET (LOSS) EARNINGS ATTRIBUTABLE TO ENSTAR ORDINARY SHAREHOLDERS | $ | (282 | ) | $ | 183 | $ | (465 | ) | (254 | )% | ||||
(1) Other income (expense) for corporate and other activities includes the amortization of fair value adjustments associated with the acquisition of DCo LLC and Morse TEC LLC.
(2) Net incurred losses and LAE for corporate and other activities includes the amortization of deferred charge assets (“DCAs”) on retroactive reinsurance contracts, fair value adjustments associated with the acquisition of companies and the changes in the discount rate and risk margin components of the fair value of assets and liabilities related to our assumed retroactive reinsurance contracts for which we have elected the fair value option. The three months ended March 31, 2022 included accelerated amortization of $24 million corresponding to increased favorable prior period development on net ultimate liabilities recorded in our Run-off segment. There was no accelerated amortization for the three months ended March 31, 2021.
NM - Not meaningful, we define NM as changes greater than or equal to +/- 300%.
For additional detail on the Enhanzed Re segment, the Legacy Underwriting segment and corporate and other activities, please refer to the Form 10-Q.
Cautionary Statement
This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include statements regarding the intent, belief or current expectations of Enstar and its management team. Investors are cautioned that any such forward-looking statements speak only as of the date they are made, are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Important risk factors regarding Enstar can be found under the heading "Risk Factors" in our Form 10-K for the year ended December 31, 2021 and are incorporated herein by reference. Furthermore, Enstar undertakes no obligation to update any written or oral forward-looking statements or publicly announce any updates or revisions to any of the forward-looking statements contained herein, to reflect any change in its expectations with regard thereto or any change in events, conditions, circumstances or assumptions underlying such statements, except as required by law.
Enstar is a NASDAQ-listed leading global (re)insurance group that offers capital release solutions through its network of group companies in Bermuda, the United States, the United Kingdom, Continental Europe, Australia, and other international locations. A market leader in completing legacy acquisitions, Enstar has acquired over 110 companies and portfolios since its formation in 2001. For further information about Enstar, see www.enstargroup.com.
For Investors: Matthew Kirk (investor.relations@enstargroup.com)For Media: Jenna Kerr (communications@enstargroup.com)
ENSTAR GROUP LIMITEDCONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED)For the Three Months Ended March 31, 2022 and 2021
Three Months Ended | |||||||
March 31, 2022 | March 31, 2021 | ||||||
(in millions of U.S. dollars, except share and per share data) | |||||||
INCOME | |||||||
Net premiums earned | $ | 34 | $ | 93 | |||
Net investment income | 80 | 62 | |||||
Net realized losses | (37 | ) | (11 | ) | |||
Net unrealized losses | (381 | ) | (10 | ) | |||
Other income | 14 | 10 | |||||
Net gain on sales of subsidiaries | — | 15 | |||||
Total income | (290 | ) | 159 | ||||
EXPENSES | |||||||
Net incurred losses and loss adjustment expenses | |||||||
Current period | 13 | 54 | |||||
Prior periods | (143 | ) | (110 | ) | |||
Total net incurred losses and loss adjustment expenses | (130 | ) | (56 | ) | |||
Policyholder benefit expenses | 12 | — | |||||
Acquisition costs | 8 | 34 | |||||
General and administrative expenses | 85 | 83 | |||||
Interest expense | 25 | 16 | |||||
Net foreign exchange losses | 3 | 3 | |||||
Total expenses | 3 | 80 | |||||
(LOSS) EARNINGS BEFORE INCOME TAXES | (293 | ) | 79 | ||||
Income tax benefit | — | 6 | |||||
Earnings from equity method investments | 31 | 118 | |||||
NET (LOSS) EARNINGS | (262 | ) | 203 | ||||
Net earnings attributable to noncontrolling interest | (11 | ) | (11 | ) | |||
NET (LOSS) EARNINGS ATTRIBUTABLE TO ENSTAR | (273 | ) | 192 | ||||
Dividends on preferred shares | (9 | ) | (9 | ) | |||
NET (LOSS) EARNINGS ATTRIBUTABLE TO ENSTAR ORDINARY SHAREHOLDERS | $ | (282 | ) | $ | 183 | ||
(Loss) earnings per ordinary share attributable to Enstar: | |||||||
Basic | $ | (16.04 | ) | $ | 8.50 | ||
Diluted | $ | (16.04 | ) | $ | 8.38 | ||
Weighted average ordinary shares outstanding: | |||||||
Basic | 17,578,019 | 21,562,341 | |||||
Diluted | 17,785,121 | 21,852,324 | |||||
ENSTAR GROUP LIMITEDCONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)As of March 31, 2022 and December 31, 2021
March 31, 2022 | December 31, 2021 | ||||||
(in millions of U.S. dollars, except share data) | |||||||
ASSETS | |||||||
Short-term investments, trading, at fair value | $ | 7 | $ | 6 | |||
Short-term investments, available-for-sale, at fair value (amortized cost: 2022 — $59; 2021 — $34; net of allowance: 2022 and 2021 — $0) | 59 | 34 | |||||
Fixed maturities, trading, at fair value | 3,247 | 3,756 | |||||
Fixed maturities, available-for-sale, at fair value (amortized cost: 2022 — $5,575; 2021 — $5,689; net of allowance: 2022 — $29; 2021 — $10) | 5,268 | 5,652 | |||||
Funds held - directly managed | 2,835 | 3,007 | |||||
Equities, at fair value (cost: 2022 — $2,325; 2021 — $1,831) | 2,444 | 1,995 | |||||
Other investments, at fair value | 2,863 | 2,333 | |||||
Equity method investments | 519 | 493 | |||||
Total investments | 17,242 | 17,276 | |||||
Cash and cash equivalents | 763 | 1,646 | |||||
Restricted cash and cash equivalents | 372 | 446 | |||||
Reinsurance balances recoverable on paid and unpaid losses (net of allowance: 2022 — $135; 2021 — $136) | 983 | 1,085 | |||||
Reinsurance balances recoverable on paid and unpaid losses, at fair value | 388 | 432 | |||||
Insurance balances recoverable (net of allowance: 2022 and 2021 — $5) | 192 | 213 | |||||
Funds held by reinsured companies | 2,241 | 2,340 | |||||
Deferred charge assets | 338 | 371 | |||||
Other assets | 721 | 620 | |||||
TOTAL ASSETS | $ | 23,240 | $ | 24,429 | |||
LIABILITIES | |||||||
Losses and loss adjustment expenses | $ | 10,744 | $ | 11,269 | |||
Losses and loss adjustment expenses, at fair value | 1,764 | 1,989 | |||||
Future policyholder benefits | 1,436 | 1,502 | |||||
Defendant asbestos and environmental liabilities | 631 | 638 | |||||
Insurance and reinsurance balances payable | 267 | 254 | |||||
Debt obligations | 1,904 | 1,691 | |||||
Other liabilities | 546 | 581 | |||||
TOTAL LIABILITIES | 17,292 | 17,924 | |||||
COMMITMENTS AND CONTINGENCIES | |||||||
REDEEMABLE NONCONTROLLING INTEREST | 181 | 179 | |||||
SHAREHOLDERS’ EQUITY | |||||||
Ordinary Shares (par value $1 each, issued and outstanding 2022: 18,101,037; 2021: 18,223,574): | |||||||
Voting Ordinary Shares (issued and outstanding 2022: 16,503,325; 2021: 16,625,862) | 17 | 17 | |||||
Non-voting convertible ordinary Series C Shares (issued and outstanding 2022 and 2021: 1,192,941) | 1 | 1 | |||||
Non-voting convertible ordinary Series E Shares (issued and outstanding 2022 and 2021: 404,771) | — | — | |||||
Preferred Shares: | |||||||
Series C Preferred Shares (issued and held in treasury 2022 and 2021: 388,571) | — | — | |||||
Series D Preferred Shares (issued and outstanding 2022 and 2021: 16,000; liquidation preference $400) | 400 | 400 | |||||
Series E Preferred Shares (issued and outstanding 2022 and 2021: 4,400; liquidation preference $110) | 110 | 110 | |||||
Treasury shares, at cost (Series C Preferred Shares 2022 and 2021: 388,571) | (422 | ) | (422 | ) | |||
Joint Share Ownership Plan (voting ordinary shares, held in trust 2022 and 2021: 565,630) | (1 | ) | (1 | ) | |||
Additional paid-in capital | 883 | 922 | |||||
Accumulated other comprehensive loss | (257 | ) | (16 | ) | |||
Retained earnings | 4,803 | 5,085 | |||||
Total Enstar Shareholders’ Equity | 5,534 | 6,096 | |||||
Noncontrolling interest | 233 | 230 | |||||
TOTAL SHAREHOLDERS’ EQUITY | 5,767 | 6,326 | |||||
TOTAL LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST AND SHAREHOLDERS’ EQUITY | $ | 23,240 | $ | 24,429 | |||
Non-GAAP Financial Measures
In addition to our key financial measures presented in accordance with GAAP, we present other non-GAAP financial measures that we use to manage our business, compare our performance against prior periods and against our peers, and as performance measures in our annual incentive compensation program.
These non-GAAP financial measures provide an additional view of our operational performance over the long-term and provide the opportunity to analyze our results in a way that is more aligned with the manner in which our management measures our underlying performance.
The presentation of these non-GAAP financial measures, which may be defined and calculated differently by other companies, is used to enhance the understanding of certain aspects of our financial performance. It is not meant to be considered in isolation, superior to, or as a substitute for the directly comparable financial measures prepared in accordance with GAAP.
We have presented the results and GAAP reconciliations for these measures further below. The following tables present more information on each non-GAAP measure.
Non-GAAP Measure | Definition | Purpose of Non-GAAP Measure over GAAP Measure | ||
Adjusted book value per ordinary share | Total Enstar ordinary shareholders' equity Divided by Number of ordinary shares outstanding, adjusted for: -the ultimate effect of any dilutive securities on the number of ordinary shares outstanding | Increases the number of ordinary shares to reflect equity awards granted but not yet vested as, over the long term, this presents a prudent view of our book value per share. We use this non-GAAP measure in our annual incentive compensation program. | ||
Adjusted return on equity | Adjusted operating income (loss) attributable to Enstar ordinary shareholders divided by adjusted opening Enstar ordinary shareholder's equity | Calculating the operating income (loss) as a percentage of our adjusted opening Enstar ordinary shareholders' equity provides a more valuable and consistent measure of the performance of our business, and enhances comparisons to prior periods:
We include the amortization of fair value adjustments as a non-GAAP adjustment to the adjusted operating income (loss) attributable to Enstar ordinary shareholders as it is considered to be a non-cash charge and not indicative of our operating results. | ||
Adjusted operating income (loss) attributable to Enstar ordinary shareholders (numerator) | Net earnings (loss) attributable to Enstar ordinary shareholders, adjusted for: -net realized and unrealized (gains) losses on fixed maturity investments and funds held-directly managed -change in fair value of insurance contracts for which we have elected the fair value option (1) -amortization of fair value adjustments -net gain/loss on purchase and sales of subsidiaries (if any) -net earnings from discontinued operations (if any) -tax effects of adjustments -adjustments attributable to noncontrolling interest | |||
Adjusted opening Enstar ordinary shareholders' equity (denominator) | Opening Enstar ordinary shareholders' equity, less: -net unrealized gains (losses) on fixed maturity investments and funds held-directly managed, -fair value of insurance contracts for which we have elected the fair value option (1), -fair value adjustments, and -net assets of held for sale or disposed subsidiaries classified as discontinued operations (if any) | |||
Adjusted total investment return (%) | Adjusted total investment return (dollars) recognized in earnings for the applicable period divided by period average adjusted total investable assets. | Provides a key measure of the return generated on the capital held in the business and is reflective of our investment strategy. Provides a consistent measure of investment returns as a percentage of all assets generating investment returns. Adjusts investment returns for the temporary impact of the change in fair value of fixed maturity securities (both credit spreads and interest rates) which we hold until the earlier of maturity or used to fund any settlement of related liabilities which are generally recorded at cost. | ||
Adjusted total investment return ($) (numerator) | Total investment return (dollars), adjusted for: -net realized and unrealized (gains) losses on fixed maturity investments and funds held-directly managed | |||
Adjusted average aggregate total investable assets (denominator) | Total average investable assets, adjusted for: -net unrealized (gains) losses on fixed maturities, AFS investments included within AOCI -net unrealized (gains) losses on fixed maturities, trading instruments | |||
Adjusted run-off liability earnings (%) | Adjusted PPD divided by average adjusted net loss reserves | Calculating the RLE as a percentage of our adjusted average net loss reserves provides a more meaningful measurement of our claims management performance. We use this measure to evaluate our ability to settle our obligations for amounts less than our initial estimate at the point of acquiring the obligations. In order to provide a complete and consistent picture of our claims performance, we combine the reduction (increase) in estimates of prior period net ultimate losses relating to our Run-off segment with the amortization of deferred charge assets, both of which are included in net incurred losses and LAE and have an inverse effect on our results. We also include our performance in managing our defendant A&E liabilities, that do not form part of loss reserves. The remaining components of net incurred losses and LAE and net loss reserves are not considered key components of our claims performance as they are either not non-life run-off in nature, or are considered to be non-cash charges that obscure our trends on a consistent basis. We use this measure to assess the performance of our claim strategies and part of the performance assessment of our past acquisitions. | ||
Adjusted prior period development (numerator) | Prior period net incurred losses and LAE, adjusted to: Remove: -Legacy Underwriting and Enhanzed Re operations -the reduction/(increase) in provisions for unallocated LAE (ULAE) -amortization of fair value adjustments, -change in fair value of insurance contracts for which we have elected the fair value option (1), and Add: -the reduction/(increase) in estimates of our defendant A&E ultimate net liabilities. | |||
Adjusted net loss reserves (denominator) | Net losses and LAE, adjusted to: Remove: -Legacy Underwriting and Enhanzed Re net loss reserves -current period net loss reserves -the net ULAE provision -net fair value adjustments associated with the acquisition of companies, -the fair value adjustments for contracts for which we have elected the fair value option (1) and Add: -net nominal defendant asbestos and environmental exposures. |
(1) Comprises the discount rate and risk margin components.
Reconciliation of GAAP to Non-GAAP Measures
The table below presents a reconciliation of BVPS to Adjusted BVPS*:
March 31, 2022 | December 31, 2021 | |||||||||||||||||||||
Equity (1) | Ordinary Shares | Per Share Amount | Equity (1) | Ordinary Shares | Per Share Amount | |||||||||||||||||
(in millions of U.S. dollars, except share and per share data) | ||||||||||||||||||||||
Book value per ordinary share | $ | 5,024 | 17,535,407 | $ | 286.51 | $ | 5,586 | 17,657,944 | $ | 316.34 | ||||||||||||
Non-GAAP adjustments: | ||||||||||||||||||||||
Share-based compensation plans | 274,080 | 315,205 | ||||||||||||||||||||
Adjusted book value per ordinary share* | $ | 5,024 | 17,809,487 | $ | 282.10 | $ | 5,586 | 17,973,149 | $ | 310.80 | ||||||||||||
(1) Equity comprises Enstar ordinary shareholders' equity, which is calculated as Enstar shareholders' equity less preferred shares ($510 million) prior to any non-GAAP adjustments.
*Non-GAAP measure.
The table below presents a reconciliation of Annualized ROE to Annualized Adjusted ROE*:
Three Months Ended | |||||||||||||||||||||||||||
March 31, 2022 | March 31, 2021 | ||||||||||||||||||||||||||
Net (loss) earnings (1) | Opening equity (1) | (Adj) ROE | Annualized (Adj) ROE | Net (loss) earnings (1) | Opening equity (1) | (Adj) ROE | Annualized (Adj) ROE | ||||||||||||||||||||
(in millions of U.S. dollars) | |||||||||||||||||||||||||||
Net (loss) earnings/Opening equity/ROE/Annualized ROE (1) | $ | (282 | ) | $ | 5,586 | (5.0 | )% | (20.2 | )% | $ | 183 | $ | 6,164 | 3.0 | % | 11.9 | % | ||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||||||
Net realized and unrealized losses on fixed maturity investments and funds held - directly managed / Net unrealized gains on fixed maturity investments and funds held - directly managed (2) | 334 | (89 | ) | 206 | (560 | ) | |||||||||||||||||||||
Change in fair value of insurance contracts for which we have elected the fair value option / Fair value of insurance contracts for which we have elected the fair value option (3) | (98 | ) | (107 | ) | (75 | ) | (33 | ) | |||||||||||||||||||
Amortization of fair value adjustments / Fair value adjustments | 2 | (106 | ) | 2 | (128 | ) | |||||||||||||||||||||
Net gain on purchase and sales of subsidiaries | — | (15 | ) | ||||||||||||||||||||||||
Tax effects of adjustments (4) | (26 | ) | (17 | ) | |||||||||||||||||||||||
Adjustments attributable to noncontrolling interest (5) | (5 | ) | 11 | ||||||||||||||||||||||||
Adjusted operating (loss) income/Adjusted opening equity/Adjusted ROE/Annualized adjusted ROE* | $ | (75 | ) | $ | 5,284 | (1.4 | )% | (5.7 | )% | $ | 295 | $ | 5,443 | 5.4 | % | 21.7 | % | ||||||||||
(1) Net (loss) earnings comprises net (loss) earnings attributable to Enstar ordinary shareholders, prior to any non-GAAP adjustments. Opening equity comprises Enstar ordinary shareholders' equity, which is calculated as opening Enstar shareholders' equity less preferred shares ($510 million), prior to any non-GAAP adjustments.
(2) Represents the net realized and unrealized losses related to fixed maturity securities. Our fixed maturity securities are held directly on our balance sheet and also within the "Funds held - directly managed" balance.
(3) Comprises the discount rate and risk margin components.
(4) Represents an aggregation of the tax expense or benefit associated with the specific country to which the pre-tax adjustment relates, calculated at the applicable jurisdictional tax rate.
(5) Represents the impact of the adjustments on the net earnings (loss) attributable to noncontrolling interest associated with the specific subsidiaries to which the adjustments relate.
*Non-GAAP measure.
The table below presents a reconciliation of PPD to Adjusted PPD* and Annualized RLE to Annualized Adjusted RLE*:
Three Months Ended | As of | Three Months Ended | |||||||||||||||||
March 31, 2022 | March 31, 2022 | December 31, 2021 | March 31, 2022 | March 31, 2022 | |||||||||||||||
PPD | Net loss reserves | Net loss reserves | Average net loss reserves | Annualized RLE % | |||||||||||||||
(in millions of U.S. dollars) | |||||||||||||||||||
PPD/net loss reserves/Annualized RLE | $ | 143 | $ | 10,962 | $ | 11,555 | $ | 11,259 | 5.1 | % | |||||||||
Non-GAAP Adjustments: | |||||||||||||||||||
Enhanzed Re | (28 | ) | (150 | ) | (181 | ) | (166 | ) | |||||||||||
Legacy Underwriting | (1 | ) | (142 | ) | (153 | ) | (147 | ) | |||||||||||
Net loss reserves - current period | — | (13 | ) | — | (7 | ) | |||||||||||||
Reduction in provisions for ULAE / Net ULAE provisions | (22 | ) | (394 | ) | (416 | ) | (405 | ) | |||||||||||
Amortization of fair value adjustments / Net fair value adjustments associated with the acquisition of companies | 2 | 104 | 106 | 105 | |||||||||||||||
Changes in fair value - fair value option / Net fair value adjustments for contracts for which we have elected the fair value option (1) | (98 | ) | 201 | 107 | 154 | ||||||||||||||
Change in estimate of net ultimate liabilities - defendant A&E / Net nominal defendant A&E liabilities | 3 | 586 | 574 | 580 | |||||||||||||||
Adjusted PPD/Adjusted net loss reserves/Annualized Adjusted RLE* | $ | (1 | ) | $ | 11,154 | $ | 11,592 | $ | 11,373 | 0.0 | % |
Three Months Ended | As of | Three Months Ended | |||||||||||||||||
March 31, 2021 | March 31, 2021 | December 31, 2020 | March 31, 2021 | March 31, 2021 | |||||||||||||||
PPD | Net loss reserves | Net loss reserves | Average net loss reserves | Annualized RLE % | |||||||||||||||
(in millions of U.S. dollars) | |||||||||||||||||||
PPD/net loss reserves/Annualized RLE | $ | 110 | $ | 9,215 | $ | 8,544 | $ | 8,880 | 5.0 | % | |||||||||
Non-GAAP Adjustments: | |||||||||||||||||||
Legacy Underwriting | (6 | ) | (153 | ) | (955 | ) | (555 | ) | |||||||||||
Net loss reserves - current period | — | (48 | ) | — | (24 | ) | |||||||||||||
Reduction in provisions for ULAE / Net ULAE provisions | (14 | ) | (396 | ) | (334 | ) | (365 | ) | |||||||||||
Amortization of fair value adjustments / Net fair value adjustments associated with the acquisition of companies | 2 | 125 | 128 | 127 | |||||||||||||||
Changes in fair value - fair value option / Net fair value adjustments for contracts for which we have elected the fair value option (1) | (75 | ) | 109 | 33 | 71 | ||||||||||||||
Change in estimate of net ultimate liabilities - defendant A&E / Net nominal defendant A&E liabilities | 9 | 599 | 615 | 607 | |||||||||||||||
Adjusted PPD/Adjusted net loss reserves/Annualized Adjusted RLE* | $ | 26 | $ | 9,451 | $ | 8,031 | $ | 8,741 | 1.2 | % | |||||||||
(1) Comprises the discount rate and risk margin components.
*Non-GAAP measure.
The table below presents a reconciliation of our Annualized TIR to our Annualized Adjusted TIR*:
Three Months Ended | |||||||
March 31, 2022 | March 31, 2021 | ||||||
(in millions of U.S. dollars) | |||||||
Net investment income | $ | 80 | $ | 62 | |||
Net realized losses | (37 | ) | (11 | ) | |||
Net unrealized losses | (381 | ) | (10 | ) | |||
Earnings from equity method investments | 31 | 118 | |||||
TIR ($) | $ | (307 | ) | $ | 159 | ||
Non-GAAP adjustment: | |||||||
Net realized and unrealized losses on fixed maturity investments and funds held-directly managed | 334 | 206 | |||||
Adjusted TIR ($)* | $ | 27 | $ | 365 | |||
Total investments | $ | 17,242 | $ | 16,553 | |||
Cash and cash equivalents, including restricted cash and cash equivalents | 1,135 | 996 | |||||
Funds held by reinsured companies | 2,241 | 663 | |||||
Total investable assets | $ | 20,618 | $ | 18,212 | |||
Average aggregate invested assets, at fair value (1) | 20,243 | 17,863 | |||||
Annualized TIR % (2) | (6.1 | )% | 3.6 | % | |||
Non-GAAP adjustment: | |||||||
Net unrealized losses (gains) on fixed maturities, AFS investments included within AOCI and net unrealized losses (gains) on fixed maturities, trading instruments | 521 | (229 | ) | ||||
Adjusted investable assets* | $ | 21,139 | $ | 17,983 | |||
Adjusted average aggregate invested assets, at fair value* (3) | 20,459 | 17,468 | |||||
Annualized adjusted TIR %* (4) | 0.5 | % | 8.4 | % | |||
(1) This amount is a two period average of the total investable assets, as presented above, and is comprised of amounts disclosed in our quarterly and annual U.S. GAAP consolidated financial statements.
(2) Annualized TIR % is calculated by dividing the annualized TIR ($) by average aggregate invested assets, at fair value.
(3) This amount is a two period average of the adjusted investable assets*, as presented above.
(4) Annualized adjusted TIR %* is calculated by dividing the annualized adjusted TIR* ($) by adjusted average aggregate invested assets, at fair value*.
*Non-GAAP measure.
ГАМИЛЬТОН, Бермудские острова, 05 мая 2022 года (GLOBE NEWSWIRE) -- Enstar Group Limited (Nasdaq: ESGR) ранее сегодня подала в SEC свой квартальный отчет по форме 10-Q, сообщив о чистом убытке в размере 282 миллионов долларов и рентабельности собственного капитала (5,0)% за три месяца, закончившихся 31 марта., 2022 год.
Комментируя результаты компании, генеральный директор Enstar Доминик Сильвестр сказал:
"Мы начали год с подписания одной из наших крупнейших в истории убыточных портфельных сделок и завершения еще одного успешного привлечения долга по конкурентоспособным ставкам, в то время как наши финансовые результаты в первом квартале отражают растущие процентные ставки и экономическую неопределенность.
Мы по-прежнему сосредоточены на обеспечении долгосрочной ценности и находимся в хорошем положении, чтобы сохранить наш импульс в эти нестабильные времена".
Результаты первого квартала включали:
*Показатель, не относящийся к GAAP; см. "Финансовые показатели, не относящиеся к GAAP" ниже для получения пояснительных примечаний и сверки с наиболее непосредственно сопоставимым показателем GAAP.
Основные операционные моменты
_______________1 Сумма предполагаемых резервов на чистые убытки, а также суммы премий и лимитов, предусмотренные в соглашении LPT, будут скорректированы для требований, выплаченных в период с 1 октября 2021 года до даты закрытия сделки в соответствии с условиями контракта.
Ключевые финансовые и операционные показатели
Мы используем следующие показатели GAAP и не-GAAP для мониторинга эффективности компании и управления ею:
Three Months Ended | ||||||||||||||
March 31, 2022 | March 31, 2021 | $ Change | % / pp / bp Change | |||||||||||
(in millions of U.S. dollars, except per share data) | ||||||||||||||
Key Earnings Metrics | ||||||||||||||
Net (loss) earnings attributable to Enstar ordinary shareholders | $ | (282 | ) | $ | 183 | $ | (465 | ) | (254 | ) % | ||||
Adjusted operating (loss) income attributable to Enstar ordinary shareholders* | $ | (75 | ) | $ | 295 | (370 | ) | (125 | ) % | |||||
ROE | (5.0 | )% | 3.0 | % | (8.0 | ) pp | ||||||||
Annualized ROE | (20.2 | )% | 11.9 | % | (32.1 | ) pp | ||||||||
Adjusted ROE* | (1.4 | )% | 5.4 | % | (6.8 | ) pp | ||||||||
Annualized Adjusted ROE* | (5.7 | )% | 21.7 | % | (27.4 | ) pp | ||||||||
Key Run-off Metrics | ||||||||||||||
Prior period development | $ | 143 | $ | 110 | 33 | 30 | % | |||||||
Adjusted prior period development* | $ | (1 | ) | $ | 26 | (27 | ) | (104 | ) % | |||||
Annualized RLE | 5.1 | % | 5.0 | % | 0.1 | pp | ||||||||
Annualized Adjusted RLE* | 0.0 | % | 1.2 | % | (1.2 | ) pp | ||||||||
Key Investment Return Metrics | ||||||||||||||
TIR | $ | (307 | ) | $ | 159 | (466 | ) | (293 | ) % | |||||
Adjusted TIR* | $ | 27 | $ | 365 | (338 | ) | (93 | ) % | ||||||
Total investable assets | $ | 20,618 | $ | 18,212 | 2,406 | 13 | % | |||||||
Adjusted total investable assets* | $ | 21,139 | $ | 17,983 | 3,156 | 18 | % | |||||||
Annualized investment book yield | 1.91 | % | 1.86 | % | 5 | bp | ||||||||
Annualized TIR | (6.1 | )% | 3.6 | % | (9.7 | ) pp | ||||||||
Annualized Adjusted TIR* | 0.5 | % | 8.4 | % | (7.9 | ) pp | ||||||||
As of | ||||||||||||||
March 31, 2022 | December 31, 2021 | |||||||||||||
Key Shareholder Metrics | ||||||||||||||
Book value per ordinary share | $ | 286.51 | $ | 316.34 | (29.83 | ) | (9.4 | ) % | ||||||
Adjusted book value per ordinary share* | $ | 282.10 | $ | 310.80 | (28.70 | ) | (9.2 | ) % | ||||||
pp - Процентный пункт(ы)bp - Базисный пункт(ы)*Показатель, не относящийся к GAAP; для выверки см. "Финансовые показатели, не относящиеся к GAAP" далее ниже.
Результаты операций по сегментам - За Три месяца, закончившихся 31 марта 2022 и 2021 годов
Сегмент стока
Ниже приводится обсуждение и анализ результатов операций для нашего сегмента стока.
Three Months Ended | ||||||||||||||
March 31, 2022 | March 31, 2021 | $ Change | % Change | |||||||||||
(in millions of U.S. dollars) | ||||||||||||||
INCOME | ||||||||||||||
Net premiums earned | $ | 17 | $ | 73 | $ | (56 | ) | (77 | )% | |||||
Other income: | ||||||||||||||
Reduction in estimates of net ultimate defendant A&E liabilities - prior periods | 3 | 9 | (6 | ) | (67 | )% | ||||||||
Reduction in estimated future defendant A&E expenses | — | 3 | (3 | ) | (100 | )% | ||||||||
All other income | 7 | 10 | (3 | ) | (30 | )% | ||||||||
Total other income | 10 | 22 | (12 | ) | (55 | )% | ||||||||
Total income | 27 | 95 | (68 | ) | (72 | )% | ||||||||
EXPENSES | ||||||||||||||
Net incurred losses and LAE: | ||||||||||||||
Current period | 11 | 44 | (33 | ) | (75 | )% | ||||||||
Prior periods: | ||||||||||||||
Reduction in estimates of net ultimate losses | (29 | ) | (25 | ) | (4 | ) | 16 | % | ||||||
Reduction in provisions for ULAE | (21 | ) | (14 | ) | (7 | ) | 50 | % | ||||||
Total prior periods | (50 | ) | (39 | ) | (11 | ) | 28 | % | ||||||
Total net incurred losses and LAE | (39 | ) | 5 | (44 | ) | NM | ||||||||
Acquisition costs | 8 | 29 | (21 | ) | (72 | )% | ||||||||
General and administrative expenses | 39 | 28 | 11 | 39 | % | |||||||||
Total expenses | 8 | 62 | (54 | ) | (87 | )% | ||||||||
SEGMENT NET EARNINGS | $ | 19 | $ | 33 | $ | (14 | ) | (42 | )% | |||||
NM - Не имеет значения, мы определяем NM как изменения, превышающие или равные +/- 300%.
Чистая прибыль нашего второго сегмента снизилась на 14 миллионов долларов, в основном из-за:
Инвестиционный сегмент
Ниже приводится обсуждение и анализ результатов деятельности нашего инвестиционного сегмента.
Three Months Ended | ||||||||||||||
March 31, | ||||||||||||||
2022 | 2021 | $ Change | % Change | |||||||||||
(in millions of U.S. dollars) | ||||||||||||||
INCOME | ||||||||||||||
Net investment income: | ||||||||||||||
Fixed income securities | $ | 68 | $ | 51 | $ | 17 | 33 | % | ||||||
Other investments, including equities | 19 | 14 | 5 | 36 | % | |||||||||
Less: Investment expenses | (11 | ) | (4 | ) | (7 | ) | 175 | % | ||||||
Total net investment income | 76 | 61 | 15 | 25 | % | |||||||||
Net realized losses: | ||||||||||||||
Fixed income securities | (35 | ) | (11 | ) | (24 | ) | 218 | % | ||||||
Other investments, including equities | (2 | ) | 1 | (3 | ) | NM | ||||||||
Net realized losses | (37 | ) | (10 | ) | (27 | ) | 270 | % | ||||||
Net unrealized losses: | ||||||||||||||
Fixed income securities | (293 | ) | (194 | ) | (99 | ) | 51 | % | ||||||
Other investments, including equities | (82 | ) | 184 | (266 | ) | (145 | )% | |||||||
Total net unrealized losses | (375 | ) | (10 | ) | (365 | ) | NM | |||||||
Total income | (336 | ) | 41 | (377 | ) | NM | ||||||||
EXPENSES | ||||||||||||||
General and administrative expenses | 9 | 3 | 6 | 200 | % | |||||||||
Total expenses | 9 | 3 | 6 | 200 | % | |||||||||
Earnings from equity method investments | 31 | 118 | (87 | ) | (74 | )% | ||||||||
SEGMENT NET (LOSS) EARNINGS | $ | (314 | ) | $ | 156 | $ | (470 | ) | NM | |||||
NM - Не имеет значения, мы определяем NM как изменения, превышающие или равные +/- 300%.
Чистый убыток сегмента от нашего инвестиционного сегмента составил $314 млн за три месяца, закончившихся 31 марта 2022 года, по сравнению с чистой прибылью сегмента в размере $156 млн за аналогичный период 2021 года, неблагоприятное изменение на $470 млн в основном из-за:
Доходы и прибыль по сегментам - За Три месяца, закончившихся 31 марта 2022 и 2021 годов
Three Months Ended | ||||||||||||||
March 31, 2022 | March 31, 2021 | $ Change | % Change | |||||||||||
(in millions of U.S. dollars) | ||||||||||||||
INCOME | ||||||||||||||
Run-off | $ | 27 | $ | 95 | $ | (68 | ) | (72 | )% | |||||
Enhanzed Re | 14 | — | 14 | NM | ||||||||||
Investments | (336 | ) | 41 | (377 | ) | NM | ||||||||
Legacy Underwriting | 2 | 13 | (11 | ) | (85 | )% | ||||||||
Subtotal | (293 | ) | 149 | (442 | ) | (297 | )% | |||||||
Corporate and other | 3 | 10 | (7 | ) | (70 | )% | ||||||||
Total income | $ | (290 | ) | $ | 159 | $ | (449 | ) | (282 | )% | ||||
SEGMENT NET (LOSS) EARNINGS | ||||||||||||||
Run-off | $ | 19 | $ | 33 | $ | (14 | ) | (42 | )% | |||||
Enhanzed Re | 29 | — | 29 | NM | ||||||||||
Investments | (314 | ) | 156 | (470 | ) | NM | ||||||||
Legacy Underwriting | — | 2 | (2 | ) | (100 | )% | ||||||||
Total segment net (loss) earnings | (266 | ) | 191 | (457 | ) | (239 | )% | |||||||
Corporate and other (1)(2) | (16 | ) | (8 | ) | (8 | ) | 100 | % | ||||||
NET (LOSS) EARNINGS ATTRIBUTABLE TO Enstar ORDINARY SHAREHOLDERS | $ | (282 | ) | $ | 183 | $ | (465 | ) | (254 | )% | ||||
(1) Прочие доходы (расходы) от корпоративной и прочей деятельности включают амортизацию корректировок справедливой стоимости, связанных с приобретением DCo LLC и Morse TEC LLC.
(2) Чистые понесенные убытки и LAE по корпоративной и прочей деятельности включают амортизацию активов с отсроченными платежами (“DCAS”) по договорам перестрахования с обратной силой, корректировки справедливой стоимости, связанные с приобретением компаний, а также изменения в ставке дисконтирования и компонентах маржи риска справедливой стоимости активов и обязательств, связанных с наши предполагаемые ретроактивные договоры перестрахования, для которых мы выбрали вариант справедливой стоимости. Три месяца, закончившихся 31 марта 2022 года, включали ускоренную амортизацию в размере 24 миллионов долларов США, что соответствует увеличению благоприятного развития событий предыдущего периода по чистым конечным обязательствам, зарегистрированным в нашем сегменте выбытия. За три месяца, закончившихся 31 марта 2021 года, ускоренная амортизация не проводилась.
NM - Не имеет значения, мы определяем NM как изменения, превышающие или равные +/- 300%.
Для получения дополнительной информации о расширенном сегменте Re, сегменте унаследованного андеррайтинга и корпоративной и другой деятельности, пожалуйста, обратитесь к форме 10-Q.
Предостерегающее заявление
Настоящий пресс-релиз содержит определенные прогнозные заявления по смыслу Закона о реформе судебных разбирательств по частным ценным бумагам 1995 года. Эти заявления включают заявления, касающиеся намерений, убеждений или текущих ожиданий Enstar и его управленческой команды. Инвесторы предупреждаются о том, что любые такие прогнозные заявления относятся только к дате их составления, не являются гарантией будущих результатов и сопряжены с рисками и неопределенностями, а также о том, что фактические результаты могут существенно отличаться от прогнозируемых в прогнозных заявлениях в результате различных факторов. Важные факторы риска, касающиеся ПСЕВДОНИМОВ_0, можно найти в разделе "Факторы риска" в нашей форме 10-K за год, закончившийся 31 декабря 2021 года, и они включены в настоящий документ в качестве ссылки. Кроме того, Enstar не берет на себя никаких обязательств обновлять какие-либо письменные или устные заявления прогнозного характера или публично объявлять о каких-либо обновлениях или пересмотре любого из заявлений прогнозного характера, содержащихся в настоящем документе, чтобы отразить любые изменения в своих ожиданиях в отношении них или любые изменения в событиях, условиях, обстоятельствах или предположениях, лежащих в основе таких заявлений, за исключением как того требует закон.
Enstar - ведущая глобальная (re) страховая группа, котирующаяся на бирже NASDAQ, которая предлагает решения по высвобождению капитала через свою сеть компаний группы на Бермудских островах, в Соединенных Штатах, Соединенном Королевстве, Континентальной Европе, Австралии и других странах. Являясь лидером рынка по завершению старых приобретений, Enstar приобрела более 110 компаний и портфелей с момента своего основания в 2001 году. Для получения дополнительной информации об Enstar см. www.enstargroup.com .
Для инвесторов: Мэтью Кирк (investor.relations@enstargroup.com )Для СМИ: Дженна Керр (communications@enstargroup.com )
Enstar GROUP LIMITED СОКРАЩЕННЫЕ КОНСОЛИДИРОВАННЫЕ ОТЧЕТЫ О ПРИБЫЛЯХ И УБЫТКАХ (НЕАУДИРОВАННЫЕ)За Три месяца, закончившихся 31 марта 2022 и 2021 годов
Three Months Ended | |||||||
March 31, 2022 | March 31, 2021 | ||||||
(in millions of U.S. dollars, except share and per share data) | |||||||
INCOME | |||||||
Net premiums earned | $ | 34 | $ | 93 | |||
Net investment income | 80 | 62 | |||||
Net realized losses | (37 | ) | (11 | ) | |||
Net unrealized losses | (381 | ) | (10 | ) | |||
Other income | 14 | 10 | |||||
Net gain on sales of subsidiaries | — | 15 | |||||
Total income | (290 | ) | 159 | ||||
EXPENSES | |||||||
Net incurred losses and loss adjustment expenses | |||||||
Current period | 13 | 54 | |||||
Prior periods | (143 | ) | (110 | ) | |||
Total net incurred losses and loss adjustment expenses | (130 | ) | (56 | ) | |||
Policyholder benefit expenses | 12 | — | |||||
Acquisition costs | 8 | 34 | |||||
General and administrative expenses | 85 | 83 | |||||
Interest expense | 25 | 16 | |||||
Net foreign exchange losses | 3 | 3 | |||||
Total expenses | 3 | 80 | |||||
(LOSS) EARNINGS BEFORE INCOME TAXES | (293 | ) | 79 | ||||
Income tax benefit | — | 6 | |||||
Earnings from equity method investments | 31 | 118 | |||||
NET (LOSS) EARNINGS | (262 | ) | 203 | ||||
Net earnings attributable to noncontrolling interest | (11 | ) | (11 | ) | |||
NET (LOSS) EARNINGS ATTRIBUTABLE TO Enstar | (273 | ) | 192 | ||||
Dividends on preferred shares | (9 | ) | (9 | ) | |||
NET (LOSS) EARNINGS ATTRIBUTABLE TO Enstar ORDINARY SHAREHOLDERS | $ | (282 | ) | $ | 183 | ||
(Loss) earnings per ordinary share attributable to Enstar: | |||||||
Basic | $ | (16.04 | ) | $ | 8.50 | ||
Diluted | $ | (16.04 | ) | $ | 8.38 | ||
Weighted average ordinary shares outstanding: | |||||||
Basic | 17,578,019 | 21,562,341 | |||||
Diluted | 17,785,121 | 21,852,324 | |||||
Enstar ГРУППОВЫЕ ОГРАНИЧЕННЫЕ СОКРАЩЕННЫЕ КОНСОЛИДИРОВАННЫЕ БАЛАНСЫ (НЕАУДИРОВАННЫЕ) По состоянию на 31 марта 2022 года и 31 декабря 2021 года
March 31, 2022 | December 31, 2021 | ||||||
(in millions of U.S. dollars, except share data) | |||||||
ASSETS | |||||||
Short-term investments, trading, at fair value | $ | 7 | $ | 6 | |||
Short-term investments, available-for-sale, at fair value (amortized cost: 2022 — $59; 2021 — $34; net of allowance: 2022 and 2021 — $0) | 59 | 34 | |||||
Fixed maturities, trading, at fair value | 3,247 | 3,756 | |||||
Fixed maturities, available-for-sale, at fair value (amortized cost: 2022 — $5,575; 2021 — $5,689; net of allowance: 2022 — $29; 2021 — $10) | 5,268 | 5,652 | |||||
Funds held - directly managed | 2,835 | 3,007 | |||||
Equities, at fair value (cost: 2022 — $2,325; 2021 — $1,831) | 2,444 | 1,995 | |||||
Other investments, at fair value | 2,863 | 2,333 | |||||
Equity method investments | 519 | 493 | |||||
Total investments | 17,242 | 17,276 | |||||
Cash and cash equivalents | 763 | 1,646 | |||||
Restricted cash and cash equivalents | 372 | 446 | |||||
Reinsurance balances recoverable on paid and unpaid losses (net of allowance: 2022 — $135; 2021 — $136) | 983 | 1,085 | |||||
Reinsurance balances recoverable on paid and unpaid losses, at fair value | 388 | 432 | |||||
Insurance balances recoverable (net of allowance: 2022 and 2021 — $5) | 192 | 213 | |||||
Funds held by reinsured companies | 2,241 | 2,340 | |||||
Deferred charge assets | 338 | 371 | |||||
Other assets | 721 | 620 | |||||
TOTAL ASSETS | $ | 23,240 | $ | 24,429 | |||
LIABILITIES | |||||||
Losses and loss adjustment expenses | $ | 10,744 | $ | 11,269 | |||
Losses and loss adjustment expenses, at fair value | 1,764 | 1,989 | |||||
Future policyholder benefits | 1,436 | 1,502 | |||||
Defendant asbestos and environmental liabilities | 631 | 638 | |||||
Insurance and reinsurance balances payable | 267 | 254 | |||||
Debt obligations | 1,904 | 1,691 | |||||
Other liabilities | 546 | 581 | |||||
TOTAL LIABILITIES | 17,292 | 17,924 | |||||
COMMITMENTS AND CONTINGENCIES | |||||||
REDEEMABLE NONCONTROLLING INTEREST | 181 | 179 | |||||
SHAREHOLDERS’ EQUITY | |||||||
Ordinary Shares (par value $1 each, issued and outstanding 2022: 18,101,037; 2021: 18,223,574): | |||||||
Voting Ordinary Shares (issued and outstanding 2022: 16,503,325; 2021: 16,625,862) | 17 | 17 | |||||
Non-voting convertible ordinary Series C Shares (issued and outstanding 2022 and 2021: 1,192,941) | 1 | 1 | |||||
Non-voting convertible ordinary Series E Shares (issued and outstanding 2022 and 2021: 404,771) | — | — | |||||
Preferred Shares: | |||||||
Series C Preferred Shares (issued and held in treasury 2022 and 2021: 388,571) | — | — | |||||
Series D Preferred Shares (issued and outstanding 2022 and 2021: 16,000; liquidation preference $400) | 400 | 400 | |||||
Series E Preferred Shares (issued and outstanding 2022 and 2021: 4,400; liquidation preference $110) | 110 | 110 | |||||
Treasury shares, at cost (Series C Preferred Shares 2022 and 2021: 388,571) | (422 | ) | (422 | ) | |||
Joint Share Ownership Plan (voting ordinary shares, held in trust 2022 and 2021: 565,630) | (1 | ) | (1 | ) | |||
Additional paid-in capital | 883 | 922 | |||||
Accumulated other comprehensive loss | (257 | ) | (16 | ) | |||
Retained earnings | 4,803 | 5,085 | |||||
Total Enstar Shareholders’ Equity | 5,534 | 6,096 | |||||
Noncontrolling interest | 233 | 230 | |||||
TOTAL SHAREHOLDERS’ EQUITY | 5,767 | 6,326 | |||||
TOTAL LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST AND SHAREHOLDERS’ EQUITY | $ | 23,240 | $ | 24,429 | |||
Финансовые показатели, не относящиеся к ОПБУ
В дополнение к нашим ключевым финансовым показателям, представленным в соответствии с GAAP, мы представляем другие финансовые показатели, не относящиеся к GAAP, которые мы используем для управления нашим бизнесом, сравнения наших результатов с предыдущими периодами и с аналогичными показателями, а также в качестве показателей эффективности в нашей ежегодной программе поощрительных компенсаций.
Эти финансовые показатели, не относящиеся к GAAP, дают дополнительное представление о нашей операционной деятельности в долгосрочной перспективе и дают возможность проанализировать наши результаты таким образом, чтобы они в большей степени соответствовали тому, как наше руководство оценивает наши основные показатели.
Представление этих финансовых показателей, не относящихся к GAAP, которые могут быть определены и рассчитаны другими компаниями по-разному, используется для улучшения понимания определенных аспектов наших финансовых показателей. Он не предназначен для того, чтобы рассматриваться изолированно, превосходить или заменять непосредственно сопоставимые финансовые показатели, подготовленные в соответствии с GAAP.
Ниже мы представили результаты и выверки по ОПБУ для этих показателей. В следующих таблицах представлена дополнительная информация по каждому показателю, не относящемуся к GAAP.
Non-GAAP Measure | Definition | Purpose of Non-GAAP Measure over GAAP Measure | ||
Adjusted book value per ordinary share | Total Enstar ordinary shareholders' equity Divided by Number of ordinary shares outstanding, adjusted for: -the ultimate effect of any dilutive securities on the number of ordinary shares outstanding | Increases the number of ordinary shares to reflect equity awards granted but not yet vested as, over the long term, this presents a prudent view of our book value per share. We use this non-GAAP measure in our annual incentive compensation program. | ||
Adjusted return on equity | Adjusted operating income (loss) attributable to Enstar ordinary shareholders divided by adjusted opening Enstar ordinary shareholder's equity | Calculating the operating income (loss) as a percentage of our adjusted opening Enstar ordinary shareholders' equity provides a more valuable and consistent measure of the performance of our business, and enhances comparisons to prior periods:
We include the amortization of fair value adjustments as a non-GAAP adjustment to the adjusted operating income (loss) attributable to Enstar ordinary shareholders as it is considered to be a non-cash charge and not indicative of our operating results. | ||
Adjusted operating income (loss) attributable to Enstar ordinary shareholders (numerator) | Net earnings (loss) attributable to Enstar ordinary shareholders, adjusted for: -net realized and unrealized (gains) losses on fixed maturity investments and funds held-directly managed -change in fair value of insurance contracts for which we have elected the fair value option (1) -amortization of fair value adjustments -net gain/loss on purchase and sales of subsidiaries (if any) -net earnings from discontinued operations (if any) -tax effects of adjustments -adjustments attributable to noncontrolling interest | |||
Adjusted opening Enstar ordinary shareholders' equity (denominator) | Opening Enstar ordinary shareholders' equity, less: -net unrealized gains (losses) on fixed maturity investments and funds held-directly managed, -fair value of insurance contracts for which we have elected the fair value option (1), -fair value adjustments, and -net assets of held for sale or disposed subsidiaries classified as discontinued operations (if any) | |||
Adjusted total investment return (%) | Adjusted total investment return (dollars) recognized in earnings for the applicable period divided by period average adjusted total investable assets. | Provides a key measure of the return generated on the capital held in the business and is reflective of our investment strategy. Provides a consistent measure of investment returns as a percentage of all assets generating investment returns. Adjusts investment returns for the temporary impact of the change in fair value of fixed maturity securities (both credit spreads and interest rates) which we hold until the earlier of maturity or used to fund any settlement of related liabilities which are generally recorded at cost. | ||
Adjusted total investment return ($) (numerator) | Total investment return (dollars), adjusted for: -net realized and unrealized (gains) losses on fixed maturity investments and funds held-directly managed | |||
Adjusted average aggregate total investable assets (denominator) | Total average investable assets, adjusted for: -net unrealized (gains) losses on fixed maturities, AFS investments included within AOCI -net unrealized (gains) losses on fixed maturities, trading instruments | |||
Adjusted run-off liability earnings (%) | Adjusted PPD divided by average adjusted net loss reserves | Calculating the RLE as a percentage of our adjusted average net loss reserves provides a more meaningful measurement of our claims management performance. We use this measure to evaluate our ability to settle our obligations for amounts less than our initial estimate at the point of acquiring the obligations. In order to provide a complete and consistent picture of our claims performance, we combine the reduction (increase) in estimates of prior period net ultimate losses relating to our Run-off segment with the amortization of deferred charge assets, both of which are included in net incurred losses and LAE and have an inverse effect on our results. We also include our performance in managing our defendant A&E liabilities, that do not form part of loss reserves. The remaining components of net incurred losses and LAE and net loss reserves are not considered key components of our claims performance as they are either not non-life run-off in nature, or are considered to be non-cash charges that obscure our trends on a consistent basis. We use this measure to assess the performance of our claim strategies and part of the performance assessment of our past acquisitions. | ||
Adjusted prior period development (numerator) | Prior period net incurred losses and LAE, adjusted to: Remove: -Legacy Underwriting and Enhanzed Re operations -the reduction/(increase) in provisions for unallocated LAE (ULAE) -amortization of fair value adjustments, -change in fair value of insurance contracts for which we have elected the fair value option (1), and Add: -the reduction/(increase) in estimates of our defendant A&E ultimate net liabilities. | |||
Adjusted net loss reserves (denominator) | Net losses and LAE, adjusted to: Remove: -Legacy Underwriting and Enhanzed Re net loss reserves -current period net loss reserves -the net ULAE provision -net fair value adjustments associated with the acquisition of companies, -the fair value adjustments for contracts for which we have elected the fair value option (1) and Add: -net nominal defendant asbestos and environmental exposures. |
(1) Включает в себя компоненты ставки дисконтирования и маржи риска.
Сверка показателей GAAP с показателями, не относящимися к GAAP
В таблице ниже представлена сверка BVP с скорректированными BVP*:
March 31, 2022 | December 31, 2021 | |||||||||||||||||||||
Equity (1) | Ordinary Shares | Per Share Amount | Equity (1) | Ordinary Shares | Per Share Amount | |||||||||||||||||
(in millions of U.S. dollars, except share and per share data) | ||||||||||||||||||||||
Book value per ordinary share | $ | 5,024 | 17,535,407 | $ | 286.51 | $ | 5,586 | 17,657,944 | $ | 316.34 | ||||||||||||
Non-GAAP adjustments: | ||||||||||||||||||||||
Share-based compensation plans | 274,080 | 315,205 | ||||||||||||||||||||
Adjusted book value per ordinary share* | $ | 5,024 | 17,809,487 | $ | 282.10 | $ | 5,586 | 17,973,149 | $ | 310.80 | ||||||||||||
(1) Собственный капитал включает собственный капитал Enstar обыкновенных акционеров, который рассчитывается как собственный капитал Enstar акционеров за вычетом привилегированных акций (510 миллионов долларов США) до любых корректировок, не связанных с GAAP.
*Показатель, не относящийся к ОПБУ.
В таблице ниже представлена сверка годовой рентабельности инвестиций с скорректированной рентабельностью инвестиций в годовом исчислении*:
Three Months Ended | |||||||||||||||||||||||||||
March 31, 2022 | March 31, 2021 | ||||||||||||||||||||||||||
Net (loss) earnings (1) | Opening equity (1) | (Adj) ROE | Annualized (Adj) ROE | Net (loss) earnings (1) | Opening equity (1) | (Adj) ROE | Annualized (Adj) ROE | ||||||||||||||||||||
(in millions of U.S. dollars) | |||||||||||||||||||||||||||
Net (loss) earnings/Opening equity/ROE/Annualized ROE (1) | $ | (282 | ) | $ | 5,586 | (5.0 | )% | (20.2 | )% | $ | 183 | $ | 6,164 | 3.0 | % | 11.9 | % | ||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||||||
Net realized and unrealized losses on fixed maturity investments and funds held - directly managed / Net unrealized gains on fixed maturity investments and funds held - directly managed (2) | 334 | (89 | ) | 206 | (560 | ) | |||||||||||||||||||||
Change in fair value of insurance contracts for which we have elected the fair value option / Fair value of insurance contracts for which we have elected the fair value option (3) | (98 | ) | (107 | ) | (75 | ) | (33 | ) | |||||||||||||||||||
Amortization of fair value adjustments / Fair value adjustments | 2 | (106 | ) | 2 | (128 | ) | |||||||||||||||||||||
Net gain on purchase and sales of subsidiaries | — | (15 | ) | ||||||||||||||||||||||||
Tax effects of adjustments (4) | (26 | ) | (17 | ) | |||||||||||||||||||||||
Adjustments attributable to noncontrolling interest (5) | (5 | ) | 11 | ||||||||||||||||||||||||
Adjusted operating (loss) income/Adjusted opening equity/Adjusted ROE/Annualized adjusted ROE* | $ | (75 | ) | $ | 5,284 | (1.4 | )% | (5.7 | )% | $ | 295 | $ | 5,443 | 5.4 | % | 21.7 | % | ||||||||||
(1) Чистая (убыточная) прибыль включает чистую (убыточную) прибыль, относящуюся к акционерам Enstar обыкновенных акций, до любых корректировок, не связанных с GAAP. Начальный капитал включает акционерный капитал Enstar обыкновенных акционеров, который рассчитывается как начальный акционерный капитал Enstar за вычетом привилегированных акций (510 миллионов долларов США) до любых корректировок, не связанных с GAAP.
(2) Представляет собой чистые реализованные и нереализованные убытки, связанные с ценными бумагами с фиксированным сроком погашения. Наши ценные бумаги с фиксированным сроком погашения хранятся непосредственно на нашем балансе, а также в балансе "Средства, удерживаемые - непосредственно управляемые".
(3) Включает в себя компоненты ставки дисконтирования и маржи риска.
(4) Представляет собой совокупность налоговых расходов или выгод, связанных с конкретной страной, к которой относится корректировка до налогообложения, рассчитанная по применимой налоговой ставке юрисдикции.
(5) Отражает влияние корректировок на чистую прибыль (убыток), относящуюся к неконтролирующей доле участия, связанной с конкретными дочерними компаниями, к которым относятся корректировки.
*Показатель, не относящийся к ОПБУ.
В таблице ниже представлена сверка PPD с скорректированным PPD* и годового RLE с годовым скорректированным RLE*:
Three Months Ended | As of | Three Months Ended | |||||||||||||||||
March 31, 2022 | March 31, 2022 | December 31, 2021 | March 31, 2022 | March 31, 2022 | |||||||||||||||
PPD | Net loss reserves | Net loss reserves | Average net loss reserves | Annualized RLE % | |||||||||||||||
(in millions of U.S. dollars) | |||||||||||||||||||
PPD/net loss reserves/Annualized RLE | $ | 143 | $ | 10,962 | $ | 11,555 | $ | 11,259 | 5.1 | % | |||||||||
Non-GAAP Adjustments: | |||||||||||||||||||
Enhanzed Re | (28 | ) | (150 | ) | (181 | ) | (166 | ) | |||||||||||
Legacy Underwriting | (1 | ) | (142 | ) | (153 | ) | (147 | ) | |||||||||||
Net loss reserves - current period | — | (13 | ) | — | (7 | ) | |||||||||||||
Reduction in provisions for ULAE / Net ULAE provisions | (22 | ) | (394 | ) | (416 | ) | (405 | ) | |||||||||||
Amortization of fair value adjustments / Net fair value adjustments associated with the acquisition of companies | 2 | 104 | 106 | 105 | |||||||||||||||
Changes in fair value - fair value option / Net fair value adjustments for contracts for which we have elected the fair value option (1) | (98 | ) | 201 | 107 | 154 | ||||||||||||||
Change in estimate of net ultimate liabilities - defendant A&E / Net nominal defendant A&E liabilities | 3 | 586 | 574 | 580 | |||||||||||||||
Adjusted PPD/Adjusted net loss reserves/Annualized Adjusted RLE* | $ | (1 | ) | $ | 11,154 | $ | 11,592 | $ | 11,373 | 0.0 | % |
Three Months Ended | As of | Three Months Ended | |||||||||||||||||
March 31, 2021 | March 31, 2021 | December 31, 2020 | March 31, 2021 | March 31, 2021 | |||||||||||||||
PPD | Net loss reserves | Net loss reserves | Average net loss reserves | Annualized RLE % | |||||||||||||||
(in millions of U.S. dollars) | |||||||||||||||||||
PPD/net loss reserves/Annualized RLE | $ | 110 | $ | 9,215 | $ | 8,544 | $ | 8,880 | 5.0 | % | |||||||||
Non-GAAP Adjustments: | |||||||||||||||||||
Legacy Underwriting | (6 | ) | (153 | ) | (955 | ) | (555 | ) | |||||||||||
Net loss reserves - current period | — | (48 | ) | — | (24 | ) | |||||||||||||
Reduction in provisions for ULAE / Net ULAE provisions | (14 | ) | (396 | ) | (334 | ) | (365 | ) | |||||||||||
Amortization of fair value adjustments / Net fair value adjustments associated with the acquisition of companies | 2 | 125 | 128 | 127 | |||||||||||||||
Changes in fair value - fair value option / Net fair value adjustments for contracts for which we have elected the fair value option (1) | (75 | ) | 109 | 33 | 71 | ||||||||||||||
Change in estimate of net ultimate liabilities - defendant A&E / Net nominal defendant A&E liabilities | 9 | 599 | 615 | 607 | |||||||||||||||
Adjusted PPD/Adjusted net loss reserves/Annualized Adjusted RLE* | $ | 26 | $ | 9,451 | $ | 8,031 | $ | 8,741 | 1.2 | % | |||||||||
(1) Включает в себя компоненты ставки дисконтирования и маржи риска.
*Показатель, не относящийся к ОПБУ.
В таблице ниже представлена сверка нашего годового TIR с нашим годовым скорректированным TIR*:
Three Months Ended | |||||||
March 31, 2022 | March 31, 2021 | ||||||
(in millions of U.S. dollars) | |||||||
Net investment income | $ | 80 | $ | 62 | |||
Net realized losses | (37 | ) | (11 | ) | |||
Net unrealized losses | (381 | ) | (10 | ) | |||
Earnings from equity method investments | 31 | 118 | |||||
TIR ($) | $ | (307 | ) | $ | 159 | ||
Non-GAAP adjustment: | |||||||
Net realized and unrealized losses on fixed maturity investments and funds held-directly managed | 334 | 206 | |||||
Adjusted TIR ($)* | $ | 27 | $ | 365 | |||
Total investments | $ | 17,242 | $ | 16,553 | |||
Cash and cash equivalents, including restricted cash and cash equivalents | 1,135 | 996 | |||||
Funds held by reinsured companies | 2,241 | 663 | |||||
Total investable assets | $ | 20,618 | $ | 18,212 | |||
Average aggregate invested assets, at fair value (1) | 20,243 | 17,863 | |||||
Annualized TIR % (2) | (6.1 | )% | 3.6 | % | |||
Non-GAAP adjustment: | |||||||
Net unrealized losses (gains) on fixed maturities, AFS investments included within AOCI and net unrealized losses (gains) on fixed maturities, trading instruments | 521 | (229 | ) | ||||
Adjusted investable assets* | $ | 21,139 | $ | 17,983 | |||
Adjusted average aggregate invested assets, at fair value* (3) | 20,459 | 17,468 | |||||
Annualized adjusted TIR %* (4) | 0.5 | % | 8.4 | % | |||
(1) Эта сумма представляет собой среднее значение за два периода от общей суммы инвестиционных активов, как представлено выше, и состоит из сумм, раскрытых в нашей ежеквартальной и годовой консолидированной финансовой отчетности по ОПБУ США.
(2) % TIR в годовом исчислении рассчитывается путем деления TIR в годовом исчислении ($) на средние совокупные инвестированные активы по справедливой стоимости.
(3) Эта сумма представляет собой среднее значение скорректированных инвестиционных активов* за два периода, как представлено выше.
(4) Скорректированный в годовом исчислении TIR %* рассчитывается путем деления скорректированного в годовом исчислении TIR* ($) на скорректированные средние совокупные инвестированные активы по справедливой стоимости*.
*Показатель, не относящийся к ОПБУ.
Показать большеПоказать меньше